Structure-based mutational analysis of ICAT residues mediating negative regulation of β-catenin co-transcriptional activity
暂无分享,去创建一个
[1] O. Sansom,et al. E-cadherin can limit the transforming properties of activating β-catenin mutations , 2015, The EMBO journal.
[2] L. Papon,et al. β-catenin inhibitor ICAT modulates the invasive motility of melanoma cells. , 2014, Cancer research.
[3] Moonsup Lee,et al. PAF and EZH2 induce Wnt/β-catenin signaling hyperactivation. , 2013, Molecular cell.
[4] F. Rambow,et al. Beta-catenin inhibits melanocyte migration but induces melanoma metastasis , 2013, Oncogene.
[5] R. Moon,et al. WNT signalling pathways as therapeutic targets in cancer , 2012, Nature Reviews Cancer.
[6] A. Bosserhoff,et al. WLS inhibits melanoma cell proliferation through the β-catenin signalling pathway and induces spontaneous metastasis , 2012, EMBO molecular medicine.
[7] Hans Clevers,et al. Wnt/β-Catenin Signaling and Disease , 2012, Cell.
[8] Jasmin H. Bavarva,et al. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression , 2011, Oncogene.
[9] Daniel Bottomly,et al. Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq , 2010, Nucleic acids research.
[10] E. Weinberg,et al. The Terminal Region of β-Catenin Promotes Stability by Shielding the Armadillo Repeats from the Axin-scaffold Destruction Complex* , 2009, The Journal of Biological Chemistry.
[11] K. Basler,et al. β-Catenin hits chromatin: regulation of Wnt target gene activation , 2009, Nature Reviews Molecular Cell Biology.
[12] Jie J. Zheng,et al. Crystal structure of a full-length beta-catenin. , 2008, Structure.
[13] R. Dummer,et al. In vivo switching of human melanoma cells between proliferative and invasive states. , 2008, Cancer research.
[14] M. Moran,et al. Large-scale mapping of human protein–protein interactions by mass spectrometry , 2007, Molecular systems biology.
[15] Jane Goodall,et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. , 2006, Genes & development.
[16] D. Fisher,et al. MITF: master regulator of melanocyte development and melanoma oncogene. , 2006, Trends in molecular medicine.
[17] L. Chin,et al. Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene , 2006, Cell.
[18] W. Weis,et al. Thermodynamics of beta-catenin-ligand interactions: the roles of the N- and C-terminal tails in modulating binding affinity. , 2006, The Journal of biological chemistry.
[19] W. Weis,et al. β-catenin directly displaces Groucho/TLE repressors from Tcf/Lef in Wnt-mediated transcription activation , 2005, Nature Structural &Molecular Biology.
[20] A. Wittinghofer,et al. Systematic Peptide Array-based Delineation of the Differential β-Catenin Interaction with Tcf4, E-Cadherin, and Adenomatous Polyposis Coli* , 2005, Journal of Biological Chemistry.
[21] N. Copeland,et al. Melanocytes and the microphthalmia transcription factor network. , 2004, Annual review of genetics.
[22] Nam-Chul Ha,et al. Mechanism of Phosphorylation-Dependent Binding of APC to β-Catenin and Its Role in β-Catenin Degradation , 2004 .
[23] T. Akiyama,et al. Anteriorization of neural fate by inhibitor of beta-catenin and T cell factor (ICAT), a negative regulator of Wnt signaling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. Gumbiner,et al. Role for ICAT in β-catenin-dependent nuclear signaling and cadherin functions , 2004 .
[25] Stephen L. Lessnick,et al. β-Catenin–induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor , 2002, The Journal of Cell Biology.
[26] W. Weis,et al. ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules. , 2002, Molecular cell.
[27] T. A. Graham,et al. The crystal structure of the beta-catenin/ICAT complex reveals the inhibitory mechanism of ICAT. , 2002, Molecular cell.
[28] H. Pehamberger,et al. The melanocyte-specific isoform of the microphthalmia transcription factor affects the phenotype of human melanoma. , 2002, Cancer research.
[29] N. Sreerama,et al. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. , 2000, Analytical biochemistry.
[30] T. A. Graham,et al. Crystal Structure of a β-Catenin/Tcf Complex , 2000, Cell.
[31] H. Varmus,et al. A comparative evaluation of β-catenin and plakoglobin signaling activity , 2000, Oncogene.
[32] T. Akiyama,et al. Inhibition of Wnt signaling by ICAT, a novel β-catenin-interacting protein , 2000, Genes & Development.
[33] William I. Weis,et al. Three-Dimensional Structure of the Armadillo Repeat Region of β-Catenin , 1997, Cell.
[34] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[35] P. Argos,et al. Knowledge‐based protein secondary structure assignment , 1995, Proteins.
[36] T. Arndt. Crystal , 2019, Springer Reference Medizin.
[37] S. Byers,et al. Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials. , 2011, Critical reviews in eukaryotic gene expression.
[38] B. Gumbiner,et al. Role for ICAT in beta-catenin-dependent nuclear signaling and cadherin functions. , 2004, American journal of physiology. Cell physiology.
[39] Nam-Chul Ha,et al. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. , 2004, Molecular cell.
[40] R. Shivdasani,et al. Structure of a human Tcf4-beta-catenin complex. , 2001, Nature structural biology.
[41] T. Akiyama,et al. Inhibition of Wnt signaling by ICAT, a novel beta-catenin-interacting protein. , 2000, Genes & development.
[42] H. Varmus,et al. A comparative evaluation of beta-catenin and plakoglobin signaling activity. , 2000, Oncogene.
[43] T. A. Graham,et al. Crystal structure of a beta-catenin/Tcf complex. , 2000, Cell.